Acadia Healthcare (ACHC) Upgraded to Hold by Zacks Investment Research

Acadia Healthcare (NASDAQ:ACHC) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday.

According to Zacks, “Acadia Healthcare is well positioned for long-term growth on the back of its inorganic strategies. Its latest Priory acquisition has substantially enhanced its asset base, making it the largest independent provider of mental health services in the U.K. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 0.8% upward over the last 30 days, which reflects investors' optimism towrads the stock. However, the company suffers from high debt, escalating interest expenses and foreign exchange fluctuation. Substantial integration risks associated with its frequent acquisitions are the major headwinds.”

A number of other equities research analysts have also commented on ACHC. BMO Capital Markets started coverage on shares of Acadia Healthcare in a report on Monday, October 16th. They set an “outperform” rating and a $52.00 price target for the company. KeyCorp reiterated a “buy” rating and set a $59.00 price target on shares of Acadia Healthcare in a report on Friday, October 20th. Cantor Fitzgerald lowered their price target on shares of Acadia Healthcare from $48.00 to $39.00 and set a “neutral” rating for the company in a report on Tuesday, October 24th. Mizuho set a $60.00 price target on shares of Acadia Healthcare and gave the company a “buy” rating in a report on Tuesday, October 24th. Finally, Robert W. Baird lowered shares of Acadia Healthcare from an “outperform” rating to a “neutral” rating and lowered their price target for the company from $55.00 to $38.00 in a report on Wednesday, October 25th. Eight analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Acadia Healthcare has a consensus rating of “Buy” and a consensus target price of $43.92.

Acadia Healthcare (ACHC) traded up $0.02 during trading hours on Monday, reaching $33.74. 1,726,061 shares of the company were exchanged, compared to its average volume of 1,303,813. Acadia Healthcare has a 52 week low of $26.92 and a 52 week high of $54.34. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 1.30. The company has a market cap of $2,940.00, a price-to-earnings ratio of 17.21, a P/E/G ratio of 1.14 and a beta of 0.85.

In other Acadia Healthcare news, Director Reeve B. Waud sold 100,000 shares of the company’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $31.80, for a total value of $3,180,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.10% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Aperio Group LLC raised its holdings in Acadia Healthcare by 4.8% in the 3rd quarter. Aperio Group LLC now owns 30,187 shares of the company’s stock worth $1,442,000 after purchasing an additional 1,370 shares in the last quarter. American International Group Inc. increased its stake in shares of Acadia Healthcare by 1.1% in the 4th quarter. American International Group Inc. now owns 168,938 shares of the company’s stock worth $5,512,000 after acquiring an additional 1,836 shares in the last quarter. Eagle Boston Investment Management Inc. increased its stake in shares of Acadia Healthcare by 1.5% in the 3rd quarter. Eagle Boston Investment Management Inc. now owns 126,677 shares of the company’s stock worth $6,031,000 after acquiring an additional 1,852 shares in the last quarter. Oregon Public Employees Retirement Fund increased its stake in shares of Acadia Healthcare by 7.8% in the 3rd quarter. Oregon Public Employees Retirement Fund now owns 30,370 shares of the company’s stock worth $1,450,000 after acquiring an additional 2,203 shares in the last quarter. Finally, Boston Private Wealth LLC increased its stake in shares of Acadia Healthcare by 2.6% in the 3rd quarter. Boston Private Wealth LLC now owns 88,019 shares of the company’s stock worth $4,204,000 after acquiring an additional 2,260 shares in the last quarter.

ILLEGAL ACTIVITY WARNING: This report was first reported by American Banking News and is the sole property of of American Banking News. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/02/12/acadia-healthcare-achc-upgraded-to-hold-by-zacks-investment-research.html.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply